# JOINT Corp: financial statements, quarterly

JYNT · Nasdaq · CIK 1612630 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/jynt.md) · [Financials](/companies/jynt/financials.md) · [Filings](/companies/jynt/filings.md) · [Insiders](/companies/jynt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/jynt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [29.5](/filings/0001628280-24-046464.md) | [12.7](/filings/0001612630-25-000033.md) | [29.7](/filings/0001612630-24-000006.md) | [30.3](/filings/0001628280-24-036301.md) | [30.2](/filings/0001628280-24-046464.md) | [14.7](/filings/0001612630-26-000022.md) | [13.1](/filings/0001612630-26-000051.md) | [13.3](/filings/0001612630-26-000066.md) | [13.4](/filings/0001612630-26-000022.md) | [15.2](/filings/0001612630-26-000022.md) | [14.8](/filings/0001612630-26-000051.md) | [15.2](/filings/0001612630-26-000066.md) |
| Cost of revenue | $m | [2.6](/filings/0001612630-25-000033.md) | [2.8](/filings/0001612630-25-000033.md) | [2.7](/filings/0001612630-26-000022.md) | [2.8](/filings/0001612630-26-000022.md) | [2.8](/filings/0001612630-26-000022.md) | [3.2](/filings/0001612630-26-000022.md) | [3.0](/filings/0001612630-26-000051.md) | [2.8](/filings/0001612630-26-000066.md) | [2.7](/filings/0001612630-26-000022.md) | [2.8](/filings/0001612630-26-000022.md) | [2.7](/filings/0001612630-26-000051.md) | [2.5](/filings/0001612630-26-000066.md) |
| Selling, general and administrative | $m | [9.0](/filings/0001612630-25-000033.md) | [8.9](/filings/0001612630-25-000033.md) | [9.9](/filings/0001612630-26-000022.md) | [11.6](/filings/0001612630-26-000022.md) | [10.3](/filings/0001612630-26-000022.md) | [10.7](/filings/0001612630-26-000022.md) | [10.8](/filings/0001612630-26-000051.md) | [11.6](/filings/0001612630-26-000066.md) | [10.6](/filings/0001612630-26-000022.md) | [11.6](/filings/0001612630-26-000022.md) | [11.2](/filings/0001612630-26-000051.md) | [12.9](/filings/0001612630-26-000066.md) |
| Operating income | $m | [(0.0)](/filings/0001612630-25-000033.md) | [1.0](/filings/0001612630-25-000033.md) | [(0.4)](/filings/0001612630-26-000022.md) | [(1.8)](/filings/0001612630-26-000022.md) | [(0.5)](/filings/0001612630-26-000022.md) | [0.8](/filings/0001612630-26-000022.md) | [(0.7)](/filings/0001612630-26-000051.md) | [(1.1)](/filings/0001612630-26-000066.md) | [0.2](/filings/0001612630-26-000022.md) | [0.7](/filings/0001612630-26-000022.md) | [0.9](/filings/0001612630-26-000051.md) | [(0.4)](/filings/0001612630-26-000066.md) |
| Income tax | $m | [(0.0)](/filings/0001612630-25-000033.md) | [11.2](/filings/0001612630-25-000033.md) | [0.0](/filings/0001612630-26-000022.md) | [0.0](/filings/0001612630-26-000022.md) | [0.0](/filings/0001612630-26-000022.md) | [(0.0)](/filings/0001612630-26-000022.md) | [0.0](/filings/0001612630-26-000051.md) | [0.0](/filings/0001612630-26-000066.md) | [0.0](/filings/0001612630-26-000022.md) | [0.0](/filings/0001612630-26-000022.md) | [0.0](/filings/0001612630-26-000051.md) | [0.0](/filings/0001612630-26-000066.md) |
| Net income | $m | [(0.7)](/filings/0001628280-24-046464.md) | [(11.0)](/filings/0001612630-25-000033.md) | [0.9](/filings/0001612630-24-000006.md) | [(3.6)](/filings/0001628280-24-036301.md) | [(3.2)](/filings/0001628280-24-046464.md) | [0.0](/filings/0001612630-26-000022.md) | [1.0](/filings/0001612630-26-000066.md) | [0.1](/filings/0001612630-26-000066.md) | [0.9](/filings/0001612630-26-000022.md) | [1.0](/filings/0001612630-26-000022.md) | [1.3](/filings/0001612630-26-000066.md) | [0.7](/filings/0001612630-26-000066.md) |
| Diluted EPS | $ per share | [(0.05)](/filings/0001612630-25-000033.md) | [(0.74)](/filings/0001612630-25-000033.md) | [0.06](/filings/0001612630-26-000022.md) | [(0.24)](/filings/0001612630-26-000022.md) | [(0.21)](/filings/0001612630-26-000022.md) | [0.00](/filings/0001612630-26-000022.md) | [0.06](/filings/0001612630-26-000051.md) | [0.01](/filings/0001612630-26-000066.md) | [0.06](/filings/0001612630-26-000022.md) | [0.07](/filings/0001612630-26-000022.md) | [0.09](/filings/0001612630-26-000051.md) | [0.05](/filings/0001612630-26-000066.md) |
| Basic EPS | $ per share | [(0.05)](/filings/0001612630-25-000033.md) | [(0.75)](/filings/0001612630-25-000033.md) | [0.06](/filings/0001612630-26-000022.md) | [(0.24)](/filings/0001612630-26-000022.md) | [(0.21)](/filings/0001612630-26-000022.md) | [0.00](/filings/0001612630-26-000022.md) | [0.06](/filings/0001612630-26-000051.md) | [0.01](/filings/0001612630-26-000066.md) | [0.06](/filings/0001612630-26-000022.md) | [0.07](/filings/0001612630-26-000022.md) | [0.09](/filings/0001612630-26-000051.md) | [0.05](/filings/0001612630-26-000066.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [16.1](/filings/0001628280-24-046464.md) | [18.2](/filings/0001612630-25-000033.md) | [18.7](/filings/0001612630-25-000035.md) | [17.5](/filings/0001612630-25-000037.md) | [20.7](/filings/0001612630-25-000068.md) | [25.1](/filings/0001612630-26-000022.md) | [21.9](/filings/0001612630-26-000051.md) | [29.8](/filings/0001612630-26-000066.md) | [29.7](/filings/0001612630-25-000068.md) | [23.6](/filings/0001612630-26-000066.md) | [20.7](/filings/0001612630-26-000051.md) | [22.2](/filings/0001612630-26-000066.md) |
| Current assets | $m | [28.4](/filings/0001612630-23-000010.md) | [44.3](/filings/0001612630-25-000033.md) | [44.6](/filings/0001612630-24-000006.md) | [43.4](/filings/0001628280-24-036301.md) | [55.2](/filings/0001628280-24-046464.md) | [74.6](/filings/0001612630-26-000022.md) | [70.7](/filings/0001612630-25-000035.md) | [63.8](/filings/0001612630-25-000037.md) | [60.5](/filings/0001612630-25-000068.md) | [52.1](/filings/0001612630-26-000066.md) | [49.6](/filings/0001612630-26-000051.md) | [43.8](/filings/0001612630-26-000066.md) |
| Total assets | $m | [98.6](/filings/0001612630-23-000010.md) | [87.2](/filings/0001612630-25-000033.md) | [85.7](/filings/0001612630-24-000006.md) | [82.4](/filings/0001628280-24-036301.md) | [79.6](/filings/0001628280-24-046464.md) | [83.2](/filings/0001612630-26-000022.md) | [80.1](/filings/0001612630-25-000035.md) | [73.2](/filings/0001612630-25-000037.md) | [69.4](/filings/0001612630-25-000068.md) | [61.0](/filings/0001612630-26-000066.md) | [57.9](/filings/0001612630-26-000051.md) | [51.6](/filings/0001612630-26-000066.md) |
| Current liabilities | $m | [27.7](/filings/0001612630-23-000010.md) | [33.6](/filings/0001612630-25-000033.md) | [33.3](/filings/0001612630-24-000006.md) | [34.0](/filings/0001628280-24-036301.md) | [38.3](/filings/0001628280-24-046464.md) | [49.0](/filings/0001612630-26-000022.md) | [42.7](/filings/0001612630-25-000035.md) | [35.5](/filings/0001612630-25-000037.md) | [33.0](/filings/0001612630-25-000068.md) | [32.8](/filings/0001612630-26-000066.md) | [30.2](/filings/0001612630-26-000051.md) | [24.0](/filings/0001612630-26-000066.md) |
| Total liabilities | $m | [63.3](/filings/0001612630-23-000010.md) | [62.4](/filings/0001612630-25-000033.md) | [59.5](/filings/0001612630-24-000006.md) | [59.2](/filings/0001628280-24-036301.md) | [59.1](/filings/0001628280-24-046464.md) | [62.5](/filings/0001612630-26-000022.md) | [57.3](/filings/0001612630-25-000035.md) | [49.9](/filings/0001612630-25-000037.md) | [46.7](/filings/0001612630-25-000068.md) | [45.9](/filings/0001612630-26-000066.md) | [42.4](/filings/0001612630-26-000051.md) | [35.8](/filings/0001612630-26-000066.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [35.3](/filings/0001612630-23-000010.md) | [24.7](/filings/0001612630-25-000033.md) | [26.2](/filings/0001612630-24-000006.md) | [23.2](/filings/0001628280-24-036301.md) | [20.5](/filings/0001628280-24-046464.md) | [20.7](/filings/0001612630-26-000022.md) | [22.8](/filings/0001612630-25-000035.md) | [23.2](/filings/0001612630-25-000037.md) | [22.7](/filings/0001612630-25-000068.md) | [15.1](/filings/0001612630-26-000066.md) | [15.5](/filings/0001612630-26-000051.md) | [15.9](/filings/0001612630-26-000066.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [3,802 d](/filings/0001628280-24-046464.md) | [3,383 d](/filings/0001612630-25-000033.md) | [2,810](/filings/0001612630-25-000035.md) | [(973) d](/filings/0001612630-25-000037.md) | [3,448 d](/filings/0001612630-25-000068.md) | [4,130 d](/filings/0001612630-26-000022.md) | [(3,701)](/filings/0001612630-26-000051.md) | [869 d](/filings/0001612630-26-000066.md) | [1,773 d](/filings/0001612630-25-000068.md) | [2,897 d](/filings/0001612630-26-000022.md) | [(1,476)](/filings/0001612630-26-000051.md) | [2,192 d](/filings/0001612630-26-000066.md) |
| Capital expenditure | $k | [1,103 d](/filings/0001628280-24-046464.md) | [1,166 d](/filings/0001612630-25-000033.md) | [395](/filings/0001612630-25-000035.md) | [262 d](/filings/0001612630-25-000037.md) | [244 d](/filings/0001612630-25-000068.md) | [284 d](/filings/0001612630-26-000022.md) | [332](/filings/0001612630-26-000051.md) | [505 d](/filings/0001612630-26-000066.md) | [318 d](/filings/0001612630-25-000068.md) | [349 d](/filings/0001612630-26-000022.md) | [235](/filings/0001612630-26-000051.md) | [256 d](/filings/0001612630-26-000066.md) |
| Share repurchases | $k | [1.2 d](/filings/0001628280-24-046464.md) | [0.0 d](/filings/0001612630-25-000033.md) | [6.6](/filings/0001612630-25-000035.md) | [3.0 d](/filings/0001612630-25-000037.md) | [(9.6) d](/filings/0001612630-25-000068.md) | [0.0 d](/filings/0001612630-26-000022.md) | [0.0](/filings/0001612630-26-000051.md) | [0.0 d](/filings/0001612630-26-000066.md) | [2,289 d](/filings/0001612630-25-000068.md) | [9,025 d](/filings/0001612630-26-000022.md) | [1,145](/filings/0001612630-26-000051.md) | [677 d](/filings/0001612630-26-000066.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [14.8](/filings/0001612630-23-000010.md) | [14.9](/filings/0001612630-24-000006.md) | [15.0](/filings/0001628280-24-036301.md) | [15.0](/filings/0001628280-24-046464.md) | [15.0](/filings/0001612630-25-000035.md) | [15.2](/filings/0001612630-25-000037.md) | [15.2](/filings/0001612630-25-000068.md) | [15.3](/filings/0001612630-26-000051.md) | [15.4](/filings/0001612630-26-000066.md) | [15.4](/filings/0001612630-25-000068.md) | [14.2](/filings/0001612630-26-000051.md) | [14.2](/filings/0001612630-26-000066.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 14,143,154 at 2026-08-03, from the cover of the [10-Q filed 2026-08-07](/filings/0001612630-26-000066.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.